Emmanuel A. Ho

4.5k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

Emmanuel A. Ho is a scholar working on Molecular Biology, Microbiology and Pharmaceutical Science. According to data from OpenAlex, Emmanuel A. Ho has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Microbiology and 12 papers in Pharmaceutical Science. Recurrent topics in Emmanuel A. Ho's work include Advanced Drug Delivery Systems (11 papers), Reproductive tract infections research (10 papers) and RNA Interference and Gene Delivery (9 papers). Emmanuel A. Ho is often cited by papers focused on Advanced Drug Delivery Systems (11 papers), Reproductive tract infections research (10 papers) and RNA Interference and Gene Delivery (9 papers). Emmanuel A. Ho collaborates with scholars based in Canada, China and United States. Emmanuel A. Ho's co-authors include Derek Chen, Jin Wang, Micheline Piquette‐Miller, Jijin Gu, Yufei Chen, Christine Allen, Patrick Lim Soo, Song Liu, Seungil Kim and Carolyn L. Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Emmanuel A. Ho

50 papers receiving 1.5k citations

Hit Papers

Challenges in the development and establishment of exosom... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel A. Ho Canada 22 610 343 310 248 164 52 1.5k
Vivek Agrahari United States 27 612 1.0× 440 1.3× 336 1.1× 420 1.7× 142 0.9× 52 2.0k
Xi Zhu China 17 857 1.4× 492 1.4× 597 1.9× 150 0.6× 172 1.0× 36 1.7k
Abdoelwaheb El Ghalbzouri Netherlands 29 595 1.0× 275 0.8× 383 1.2× 447 1.8× 52 0.3× 67 2.6k
Amanda E. Brooks United States 19 837 1.4× 586 1.7× 303 1.0× 59 0.2× 72 0.4× 69 1.8k
Zhengyi Cao United States 21 998 1.6× 517 1.5× 464 1.5× 131 0.5× 104 0.6× 53 2.2k
Xiyu Ke United States 24 699 1.1× 778 2.3× 491 1.6× 178 0.7× 37 0.2× 32 1.8k
Liya Ye China 23 1.3k 2.1× 559 1.6× 341 1.1× 195 0.8× 221 1.3× 58 2.3k
Qilin Li China 23 478 0.8× 360 1.0× 436 1.4× 94 0.4× 135 0.8× 59 1.4k
Jiaqi Xu China 16 812 1.3× 371 1.1× 855 2.8× 79 0.3× 122 0.7× 30 1.9k
Hiroaki Okada Japan 27 902 1.5× 625 1.8× 300 1.0× 872 3.5× 74 0.5× 75 2.4k

Countries citing papers authored by Emmanuel A. Ho

Since Specialization
Citations

This map shows the geographic impact of Emmanuel A. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel A. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel A. Ho more than expected).

Fields of papers citing papers by Emmanuel A. Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel A. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel A. Ho. The network helps show where Emmanuel A. Ho may publish in the future.

Co-authorship network of co-authors of Emmanuel A. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel A. Ho. A scholar is included among the top collaborators of Emmanuel A. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel A. Ho. Emmanuel A. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Chen, et al.. (2025). Ureasil-polyether hybrid polymer-based vaginal ovules for combination therapy in the treatment of vulvovaginal candidiasis. Drug Delivery and Translational Research. 15(12). 4742–4760. 1 indexed citations
2.
Ho, Emmanuel A., et al.. (2024). Formulating biopharmaceuticals using three-dimensional printing. Journal of Pharmacy & Pharmaceutical Sciences. 27. 12797–12797. 3 indexed citations
3.
Khan, Samiullah, Chi Wai, & Emmanuel A. Ho. (2024). Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug Delivery and Translational Research. 15(6). 1828–1876. 1 indexed citations
4.
Ho, Emmanuel A., et al.. (2024). Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae. Drug Delivery and Translational Research. 15(5). 1739–1754.
5.
Shafiq, Muhammad, et al.. (2023). An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers. Journal of Controlled Release. 362. 446–467. 36 indexed citations
6.
Ho, Emmanuel A., et al.. (2021). Sustainable Materials for Fused Deposition Modeling 3D Printing Applications. Advanced Engineering Materials. 23(7). 53 indexed citations
7.
Chen, Yufei, et al.. (2021). Segmented intravaginal ring for the combination delivery of hydroxychloroquine and anti-CCR5 siRNA nanoparticles as a potential strategy for preventing HIV infection. Drug Delivery and Translational Research. 12(4). 816–825. 3 indexed citations
8.
Lajoie, Julie, Geneviève Boily-Larouche, Julius Oyugi, et al.. (2021). Low-Dose Acetylsalicylic Acid Reduces T Cell Immune Activation: Potential Implications for HIV Prevention. Frontiers in Immunology. 12. 778455–778455. 9 indexed citations
9.
Qin, Na, Pei Zhao, Emmanuel A. Ho, Gongming Xin, & Carolyn L. Ren. (2020). Microfluidic Technology for Antibacterial Resistance Study and Antibiotic Susceptibility Testing: Review and Perspective. ACS Sensors. 6(1). 3–21. 63 indexed citations
10.
Ho, Emmanuel A., et al.. (2019). Autophagy induction and PDGFR-β knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection. Scientific Reports. 9(1). 1306–1306. 27 indexed citations
11.
Kim, Seungil, et al.. (2018). Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines. Acta Biomaterialia. 82. 12–23. 34 indexed citations
12.
Chen, Yufei, et al.. (2018). Implant delivering hydroxychloroquine attenuates vaginal T lymphocyte activation and inflammation. Journal of Controlled Release. 277. 102–113. 11 indexed citations
13.
Gu, Jijin, et al.. (2017). Dynamic mechanical behaviour of nanoparticle loaded biodegradable PVA films for vaginal drug delivery. Journal of Biomaterials Applications. 32(8). 1119–1126. 18 indexed citations
14.
Ho, Emmanuel A., et al.. (2017). A new strategy for battling bacterial resistance: Turning potent, non-selective and potentially non-resistance-inducing biocides into selective ones. Nanomedicine Nanotechnology Biology and Medicine. 14(2). 471–481. 12 indexed citations
15.
Kim, Seungil, Yufei Chen, Emmanuel A. Ho, & Song Liu. (2016). Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery. Acta Biomaterialia. 47. 100–112. 37 indexed citations
16.
Ho, Emmanuel A., et al.. (2014). Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine. Drug Design Development and Therapy. 8. 1801–1801. 26 indexed citations
17.
Chen, Yufei, et al.. (2013). Advancements in the field of intravaginal siRNA delivery. Journal of Controlled Release. 167(1). 29–39. 46 indexed citations
18.
19.
Soo, Patrick Lim, Jaepyoung Cho, Justin Grant, et al.. (2007). Drug release mechanism of paclitaxel from a chitosan–lipid implant system: Effect of swelling, degradation and morphology. European Journal of Pharmaceutics and Biopharmaceutics. 69(1). 149–157. 64 indexed citations
20.
Ho, Emmanuel A., Vessela Vassileva, Christine Allen, & Micheline Piquette‐Miller. (2005). In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel. Journal of Controlled Release. 104(1). 181–191. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026